End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.91 MXN | -0.24% | -2.42% | +19.42% |
Sales 2024 * | 17.82B 1.07B | Sales 2025 * | 19.12B 1.15B | Capitalization | 16.03B 967M |
---|---|---|---|---|---|
Net income 2024 * | 1.98B 119M | Net income 2025 * | 2.22B 134M | EV / Sales 2024 * | 1.09 x |
Net Debt 2024 * | 3.45B 208M | Net Debt 2025 * | 2.83B 171M | EV / Sales 2025 * | 0.99 x |
P/E ratio 2024 * |
7.69
x | P/E ratio 2025 * |
7.78
x | Employees | 1,783 |
Yield 2024 * |
-
| Yield 2025 * |
1.98% | Free-Float | 69.81% |
Latest transcript on Genomma Lab Internacional, S.A.B. de C.V.
1 day | -0.24% | ||
1 week | -2.42% | ||
Current month | +1.20% | ||
1 month | +15.98% | ||
3 months | +33.57% | ||
6 months | +19.76% | ||
Current year | +19.42% |
Managers | Title | Age | Since |
---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | - |
Founder | - | 96-10-29 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Burkhard Wittek
BRD | Director/Board Member | 70 | 18-04-17 |
Director/Board Member | - | - | |
Founder | - | 96-10-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 15 M€ | -1.62% | - | |
0.04% | 32 M€ | +9.08% | - | |
0.01% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +5.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 16.91 | -0.24% | 4,571,367 |
24-05-16 | 16.95 | -0.88% | 3,143,736 |
24-05-15 | 17.1 | +0.83% | 5,776,938 |
24-05-14 | 16.96 | -1.85% | 2,451,974 |
24-05-13 | 17.28 | -0.29% | 1,752,150 |
End-of-day quote Mexican S.E., May 16, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.42% | 965M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- LAB B Stock